Simon Portsmouth, MBChB, MD, FRCP, graduated from Sheffield University Medical School UK in 1992.
He became a specialist in HIV medicine and genitourinary medicine in 2003 and was Consultant and Lead Clinician in HIV medicine at St Mary’s Hospital, London until 2008.
In 2008 he joined Pfizer as a Medical Advisor in HIV medicine and in 2009 became a Medical Director in Clinical Development and Medical Affairs.
In 2015 he joined Shionogi Inc in Florham park NJ, and is currently Senior Vice President and head of Clinical Development with an interest in development of medicines for infectious diseases. Recent development activities include the successful New Drug application for Fetroja and Zofluza, and the clinical development of Ensitrelvir, a 3CL protease inhibitor for SARS-Co-V2.
